188 related articles for article (PubMed ID: 33807227)
1. A Theoretical Approach to Coupling the Epithelial-Mesenchymal Transition (EMT) to Extracellular Matrix (ECM) Stiffness via LOXL2.
Deng Y; Chakraborty P; Jolly MK; Levine H
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33807227
[TBL] [Abstract][Full Text] [Related]
2. ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis.
Peng DH; Ungewiss C; Tong P; Byers LA; Wang J; Canales JR; Villalobos PA; Uraoka N; Mino B; Behrens C; Wistuba II; Han RI; Wanna CA; Fahrenholtz M; Grande-Allen KJ; Creighton CJ; Gibbons DL
Oncogene; 2017 Apr; 36(14):1925-1938. PubMed ID: 27694892
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
[TBL] [Abstract][Full Text] [Related]
4. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
Preca BT; Bajdak K; Mock K; Lehmann W; Sundararajan V; Bronsert P; Matzge-Ogi A; Orian-Rousseau V; Brabletz S; Brabletz T; Maurer J; Stemmler MP
Oncotarget; 2017 Feb; 8(7):11530-11543. PubMed ID: 28086235
[TBL] [Abstract][Full Text] [Related]
5. Biophysics Role and Biomimetic Culture Systems of ECM Stiffness in Cancer EMT.
Tian H; Shi H; Yu J; Ge S; Ruan J
Glob Chall; 2022 Jun; 6(6):2100094. PubMed ID: 35712024
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix density promotes EMT by weakening cell-cell adhesions.
Kumar S; Das A; Sen S
Mol Biosyst; 2014 Apr; 10(4):838-50. PubMed ID: 24481128
[TBL] [Abstract][Full Text] [Related]
7. LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition.
Cuevas EP; Moreno-Bueno G; Canesin G; Santos V; Portillo F; Cano A
Biol Open; 2014 Feb; 3(2):129-37. PubMed ID: 24414204
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
9. LOXL2 in cancer: regulation, downstream effectors and novel roles.
Wen B; Xu LY; Li EM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188435. PubMed ID: 32976981
[TBL] [Abstract][Full Text] [Related]
10. Topographic confinement of epithelial clusters induces epithelial-to-mesenchymal transition in compliant matrices.
Nasrollahi S; Pathak A
Sci Rep; 2016 Jan; 6():18831. PubMed ID: 26728047
[TBL] [Abstract][Full Text] [Related]
11. Pin1/YAP pathway mediates matrix stiffness-induced epithelial-mesenchymal transition driving cervical cancer metastasis via a non-Hippo mechanism.
Yang L; Li J; Zang G; Song S; Sun Z; Li X; Li Y; Xie Z; Zhang G; Gui N; Zhu S; Chen T; Cai Y; Zhao Y
Bioeng Transl Med; 2023 Jan; 8(1):e10375. PubMed ID: 36684109
[TBL] [Abstract][Full Text] [Related]
12. LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype.
Cao C; Lin S; Zhi W; Lazare C; Meng Y; Wu P; Gao P; Wei J; Wu P
Front Oncol; 2020; 10():284. PubMed ID: 32211324
[TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.
de Jong OG; van der Waals LM; Kools FRW; Verhaar MC; van Balkom BWM
J Cell Physiol; 2019 Jul; 234(7):10260-10269. PubMed ID: 30387148
[TBL] [Abstract][Full Text] [Related]
14. Material Strategies for Modulating Epithelial to Mesenchymal Transitions.
Mihalko EP; Brown AC
ACS Biomater Sci Eng; 2018 Apr; 4(4):1149-1161. PubMed ID: 33418653
[TBL] [Abstract][Full Text] [Related]
15. Mechanotactic Activation of TGF-β by PEDOT Artificial Microenvironments Triggers Epithelial to Mesenchymal Transition.
Dhawan U; Wang WL; Gautam B; Aerathupalathu Janardhanan J; Hsiao PC; Tu HL; Yu HH
Adv Biosyst; 2020 Feb; 4(2):e1900165. PubMed ID: 32293138
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
17. Matrix stiffness regulates epithelial-mesenchymal transition via cytoskeletal remodeling and MRTF-A translocation in osteosarcoma cells.
Dai J; Qin L; Chen Y; Wang H; Lin G; Li X; Liao H; Fang H
J Mech Behav Biomed Mater; 2019 Feb; 90():226-238. PubMed ID: 30384218
[TBL] [Abstract][Full Text] [Related]
18. Type II Epithelial-Mesenchymal Transition Upregulates Protein N-Glycosylation To Maintain Proteostasis and Extracellular Matrix Production.
Zhang J; Jamaluddin M; Zhang Y; Widen SG; Sun H; Brasier AR; Zhao Y
J Proteome Res; 2019 Sep; 18(9):3447-3460. PubMed ID: 31424945
[TBL] [Abstract][Full Text] [Related]
19. Mechanochemical Signaling of the Extracellular Matrix in Epithelial-Mesenchymal Transition.
Scott LE; Weinberg SH; Lemmon CA
Front Cell Dev Biol; 2019; 7():135. PubMed ID: 31380370
[TBL] [Abstract][Full Text] [Related]
20. An extracellular matrix (ECM) model at high malignant colorectal tumor increases chondroitin sulfate chains to promote epithelial-mesenchymal transition and chemoresistance acquisition.
Hoshiba T
Exp Cell Res; 2018 Sep; 370(2):571-578. PubMed ID: 30016638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
